Trial NCT01650805

View at ClinicalTrials.gov 
Org. Study IDs: AP24534-12-301

Last trial update was posted on 2014-11-17

MeSH Interventions

Imatinib Mesylate Ponatinib

MeSH Conditions

Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid

Other Conditions

Chronic Myeloid Leukemia

Stopping Reasons

Study terminated based on evaluation of safety data.

Limitations And Caveats

Trial was discontinued early.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID